<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00210223</url>
  </required_header>
  <id_info>
    <org_study_id>IB2004-16</org_study_id>
    <secondary_id>RF SEIN</secondary_id>
    <nct_id>NCT00210223</nct_id>
  </id_info>
  <brief_title>Radiofrequency of Breast Cancers in Non Surgical Patients</brief_title>
  <acronym>RF SEIN</acronym>
  <official_title>Radiofrequency of Breast Cancers : Pilot Study in Non Surgical Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut Bergonié</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut Bergonié</source>
  <brief_summary>
    <textblock>
      To treat breast tumors in non surgical patients with percutaneous technique (radiofrequency).
      Prospective evaluation of treatment efficiency and tolerance based on clinical and
      radiological evaluation
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2004</start_date>
  <completion_date type="Actual">July 2006</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To know at 6 months the efficacy of radiofrequency based on</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>- no local recurrence (detected with magnetic resonance imaging)</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>- no palpable mass on clinical examination</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>To evaluate every 2 months, until 6 months :</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>- the late complications of the percutaneous technique</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>- the pain felt by the patients, during and after the radiofrequency</measure>
  </secondary_outcome>
  <enrollment type="Actual">15</enrollment>
  <condition>Breast Cancer</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Radiofrequency</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Patients more than 70 years old

          -  Breast tumors with estrogen receptors

          -  Non surgical patients

          -  Life expectancy more than 6 months

        Exclusion criteria:

          -  Presence of a pace maker

          -  Tumors measuring more than 30 mm on ultrasound evaluation, located less than 10 mm
             from skin, nipple, or pectoral muscle

          -  Coagulation disorders

          -  Contra indications to magnetic resonance imaging or computed tomography with contrast
             medium injection

          -  Non visible lesions on magnetic resonance imaging or computed tomography with contrast
             medium injection
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>70 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fabienne VALENTIN, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institut Bergonié</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institut Bergonié - Centre Régional de Luttre Contre le Cancer de Bordeaux et du Sud Ouest</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 13, 2005</study_first_submitted>
  <study_first_submitted_qc>September 13, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 21, 2005</study_first_posted>
  <last_update_submitted>July 25, 2013</last_update_submitted>
  <last_update_submitted_qc>July 25, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 26, 2013</last_update_posted>
  <keyword>Radiofrequency</keyword>
  <keyword>Percutaneous technique</keyword>
  <keyword>breast cancer</keyword>
  <keyword>tolerance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

